Metabolomics and in-silico analysis reveal critical energy deregulations in animal models of Parkinson's disease.
Parkinson's disease (PD) is a multifactorial disease known to result from a variety of factors. Although age is the principal risk factor, other etiological mechanisms have been identified, including gene mutations and exposure to toxins. Deregulation of energy metabolism, mostly through the lo...
Guardado en:
Autores principales: | Pierre O Poliquin, Jingkui Chen, Mathieu Cloutier, Louis-Éric Trudeau, Mario Jolicoeur |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9835fb7fa69548c4a94c0c2add482d44 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
por: Eleanor Sinclair, et al.
Publicado: (2021) -
Procalcitonin metabolomics in the critically ill reveal relationships between inflammation intensity and energy utilization pathways
por: Hirotada Kobayashi, et al.
Publicado: (2021) -
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
por: Sarah Vascellari, et al.
Publicado: (2020) -
Energy homeostasis deregulation is attenuated by TUDCA treatment in streptozotocin-induced Alzheimer’s disease mice model
por: Lucas Zangerolamo, et al.
Publicado: (2021) -
iNOS promotes hypothalamic insulin resistance associated with deregulation of energy balance and obesity in rodents
por: Carlos Kiyoshi Katashima, et al.
Publicado: (2017)